Role of Recurrence Pattern Multiplicity in Predicting Post-recurrence Survival in Patients Who Underwent Curative Gastrectomy for Gastric Cancer
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Multiple recurrence patterns after gastric cancer surgery significantly predict shorter survival. Identifying these patterns is crucial for understanding post-recurrence survival and guiding treatment strategies.
Area Of Science
- Oncology
- Surgical Oncology
- Gastroenterology
Background
- Gastric cancer (GC) recurrence after curative surgery remains a significant clinical challenge.
- Understanding recurrence patterns is vital for improving patient outcomes and survival.
Purpose Of The Study
- To investigate gastric cancer recurrence patterns following curative gastrectomy.
- To analyze the prognostic value of these recurrence patterns for post-recurrence survival (PRS).
Main Methods
- Retrospective review of 204 patients with recurrent GC post-curative gastrectomy.
- Analysis of specific recurrence patterns (lymph node, peritoneal, hematogenous) and their multiplicity.
- Prognostic evaluation of recurrence patterns for PRS.
Main Results
- Median PRS was 8.3 months.
- Single recurrence patterns did not significantly differ in PRS.
- Multiple recurrence patterns were associated with significantly shorter PRS (3.9 vs. 10.2 months).
- Multiple recurrence patterns were independent prognostic factors for poor PRS.
Conclusions
- Multiple recurrence patterns, not specific types, are key predictors of poor post-recurrence survival.
- Identifying multiple recurrence patterns is critical for prognostic assessment in gastric cancer patients.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Times Are Positively Skewed
Survival times often exhibit positive skewness, unlike the normal distribution assumed...